Pediatric Emergency Drug Preparation JJ 1688639110
Pediatric Emergency Drug Preparation JJ 1688639110
Pediatric Emergency Drug Preparation JJ 1688639110
0.3mg/kg/dose
Decant exact
Rapid push (<1m)
0.1mg/kg then incremental Proximal vein or
adenosine of exact dose 0.5mg/kg/dose
SVT IV IO NEAT NEAT 3mg/mL 0.2mg/kg then doses for CVL preferred;
6mg/2mL then large (1m-12yr)
0.3mg/kg easy/rapid see SVT algorithm.
volume flush 12mg/dose
administration
(>12yr)
adrenaline
100 10 See VF/Pulseless VT and
1mg/10mL minijet Cardiac arrest IV IO N/A N/A 0.1 mL/kg Rapid push 1mg
micrograms/mL micrograms/kg Asystole/PEA protocol
1:10,000
1mg
aTROpine Prevention or Rx 200 20 See Bradycardia
IV IO N/A N/A 0.1mL/kg Rapid push Repeat to
1mg/5mL minijet of bradycardia micrograms/mL micrograms/kg protocol
total 2mg
1mg
aTROpine Prevention or Rx 100 20 See Bradycardia
IV IO N/A N/A 0.2mL/kg Rapid push Repeat to
1mg/10mL minijet of bradycardia micrograms/mL micrograms/kg protocol
total 2mg
aTROpine
Adjunct 100 20
600micrograms/mL IV IO 0.9% NaCl 6mL 0.2 mL/kg Slow push 1mg
during RSI micrograms/mL micrograms/kg
(adjunct to RSI)
Over 3min
DIazepam Beware hypotension and
Seizures IV IO 0.9% NaCl 10mL 1mg/mL 0.1-0.4mg/kg 0.1-0.4mL/kg Max rate 10mg
10mg/2mL respiratory depression
1-2mg/min
15 Medical Officer
digOXIN Atrial Draw up prescribed dose 250microg
IV IO 0.9% NaCl micrograms/kg 3-5 min to administer;
500micrograms/2mL fibrillation & make up to 10mL (half load)
(HALF LOAD) dosing varies with age.
Endorsed by Medical Emergency Advisory Committee and Medicines Advisory Committee September 2017 – v2.1 Children’s Health Queensland Hospital and Health Service
Paediatric Emergency Drug Preparation
Dilute Vol. to Final drug Volume Delivery Max single
Drug Indications Route with dilute to concentration Dose to give speed dose Other comments
1 to 2
fentaNYL 10 Use with caution under
Analgesia IV IO 0.9% NaCl 10mL micrograms/kg 0.1-0.2mL/kg Over 3-5 min 100 micrograms
100 micrograms/2mL micrograms/mL 6 months
(less in infants)
Over
hydroCORTisone Water for Add 0.04- 30 seconds
IV IO 50mg/mL 2-4mg/kg 240mg Inject over 10 minutes
100mg powder Injection 2mL WFI 0.08mL/kg for doses
under 100mg
LevETIRAcetam
Prolonged Infuse over IPA for emergency
(Keppra) IV IO 0.9% NaCl 10mL 50mg/mL Load 40mg/kg 0.8mL/kg 2500mg
seizures 5 minutes seizure management
500mg/5mL
Drop into
NB: Apnoea and respiratory
MIDazolam Sedation Buccal alternate
N/A N/A 5mg/mL 0.3mg/kg 0.06mL/kg 10mg depression, especially if
5mg/mL seizures Nasal nostrils over
used with opiate
15 seconds
NB: Apnoea and respiratory
MIDazolam Sedation Slow push in depression, especially if
IV IO 0.9% NaCl 5mL 1mg/mL 0.15mg/kg 0.15mL/kg 10mg
5mg/mL seizures aliquots used with opiate; reversal
agent: Flumazenil
NB: Apnoea and respiratory
MIDazolam Sedation
IM N/A N/A 5mg/mL 0.2mg/kg 0.04mL/kg 10mg depression, especially if
5mg/mL seizures
used with opiate
Weight
propOFol Caution in the
Induction/seizure IV IO N/A N/A 10mg/mL 1-2mg/kg 0.1-0.2mL/kg Over 30 sec dependent as
200mg/20mL unstable patient
lipophilic
Onset 1-3mins;
rocuronium
Muscle relaxant IV IO N/A N/A 10mg/mL 1mg/kg 0.1mL/kg Rapid push 1.2mg/kg lasts 20-35min; use red
50mg/5mL
barrel syringe if available
Endorsed by Medical Emergency Advisory Committee and Medicines Advisory Committee September 2017 – v2.1 Children’s Health Queensland Hospital and Health Service
Paediatric Emergency Drug Preparation
Dilute Vol. to Final drug Volume Delivery Max single
Drug Indications Route with dilute to concentration Dose to give speed dose Other comments
Endorsed by Medical Emergency Advisory Committee and Medicines Advisory Committee September 2017 – v2.1 Children’s Health Queensland Hospital and Health Service
Paediatric Resuscitation Table
WEIGHT CALCULATION
< 12 mths = (Age in months +9) / 2 kg
3 5 10 15 20 25 30 35 40 45 50
1 - 5yrs = (Age in years x 2) + 10
ROUTE
5 - 14yrs = Age in years x 4
Adrenaline
IV mL
(1:10,000 – minijet) 0.3 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
IO
0.1 mL/kg (10 micrograms/kg)
Adrenaline
mL
(1:1000 – ampoule) IM 0.03 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5
0.01 mL/kg (10 micrograms/kg)
Adenosine
IV mL
6mg/2mL 0.1 0.17 0.3 0.5 0.67 0.83 1 1.2 1.3 1.5 1.6
IO
Dose: 0.03mL/kg (0.1mg/kg)
Atropine
IV mL
(1mg/5mL – minijet) 0.3 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
IO
0.1 mL/kg (20 micrograms/kg)
Atropine
IV mL
(1mg/10mL – minijet) 0.6 1 2 3 4 5 6 7 8 9 10
IO
0.2 mL/kg (20 micrograms/kg)
Amiodarone
(150 mg/3 mL ampoule) (5 mg/kg)
IV mL
Final concentration = 10 mg/mL 1.5 2.5 5 7.5 10 12.5 15 17.5 20 22.5 25
IO
mL post dilution. See Emergency
Drug Preparation sheet for Dilution POST DILUTION
Midazolam
EMERGENCY DRUGS
mL
(5 mg/1 mL – ampoule) 0.18 0.3 0.6 0.9 1.2 1.5 1.8 2.0 2.0 2.0 2.0
Nasal
Buccal
Glucose 10% IV mL
6 10 20 30 40 50 60 70 80 90 100
2 mL/kg IO
Volume expansion 10 mL/kg 30 50 100 150 200 250 300 350 400 450 500
10 - 20 mL/kg IV mL
IO
20 mL/kg 60 100 200 300 400 500 600 700 800 900 1000
Defibrillation VF / pulseless VT: 4 J/kg J 12 20 40 60 80 100 120 140 160 180 200
Endotracheal Uncuffed (age/4) +4 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.0 6.5 6.5 7.0
tube size
mm
Microcuffed 3.0 3.0 3.5 4.0 4.5 5.0 5.5 5.5 6.0 6.0 6.5
ETT
FrG
Nasogastric tube size 5-8 10 12
NGT
WEIGHT kg 3 5 10 15 20 25 30 35 40 45 50
Endorsed by Medical Emergency Advisory Committee and Medicines Advisory Committee September 2017 – v2.1 Children’s Health Queensland Hospital and Health Service
Paediatric Emergency Drug Preparation
The use of this Paediatric Emergency Drug Preparation table in other Queensland Health facilities is outside the scope of this document. The local Executive Director of Medical
Services (EDMS) must be consulted prior to the implementation of this document at a regional site. The information contained in this document should be read in conjunction with
hospital specific protocols and procedures as specialised work areas may use different methods to those included in this guideline. Whilst every effort has been taken in preparing
this resource, Children’s Health Queensland accepts no responsibility for any errors, omissions or inaccuracies contained in this document. If in doubt, refer to the manufacturer’s
product information and the references contained within the document.